Article
Haplobanking induced pluripotent stem cells for clinical use
28 Oct 2020
Abstract excerpt
The development of induced pluripotent stem cells (iPSCs) by Shinya Yamanaka and colleagues in 2006 has led to a potential new paradigm in cellular therapeutics, including the possibility of producing patient-specific, disease-specific and immune matched allogeneic cell therapies. One can envisage two routes to immunologically compatible iPSC therapies: using genetic modification to generate a 'universal donor'...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
